Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-12-22

Clinical Trial Update: Treatment of Mitral Regurgitation Using a Minimally Invasive Approach With the HARPOON Device. [NA]

View source ↗

Summary

A clinical trial update on treating mitral regurgitation with the HARPOON minimally invasive device shows terminated status with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HARPOON

Snippet

Sponsor: Edwards Lifesciences | Conditions: Mitral Regurgitation | NA | Status: TERMINATED | Results posted: 2023-12-22